| Metric | Q3 2026 | Q2 2026 | Q3 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $742M | $728M | $665M | 1.9% | 11.6% |
| Op. Income | $23M | $41M | -$16M | -43.9% | 243.8% |
| Gross Margin | 77.1% | 76.9% | 76.4% | 0.2pp | 0.7pp |
| Net Margin | 5.8% | 9.2% | 2.4% | -3.4pp | 3.4pp |
| EPS (Diluted) | $0.24 | $0.37 | $0.09 | -35.1% | 156.1% |
| Free Cash Flow | $214M | $162M | $154M | 32.1% | 39.0% |
| Item | Amount |
|---|---|
| REVENUE | $742M |
| Cost of Revenue | $170M |
| GROSS PROFIT | $572M |
| R&D Expenses | $160M |
| Selling & Marketing | $271M |
| General & Administrative | $118M |
| SG&A Expenses | $389M |
| Other Expenses | $0 |
| Operating Expenses | $549M |
| Cost & Expenses | $719M |
| OPERATING INCOME | $23M |
| Interest Income | $28M |
| Interest Expense | $1M |
| Other Income/Expenses | $27M |
| INCOME BEFORE TAX | $50M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $43M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $43M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $43M |
| D&A | $24M |
| EBIT | $51M |
| EBITDA | $75M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $742M |
| Cost of Revenue | $170M |
| GROSS PROFIT | $572M |
| R&D Expenses | $160M |
| Selling & Marketing | $271M |
| General & Administrative | $118M |
| SG&A Expenses | $389M |
| Other Expenses | $0 |
| Operating Expenses | $549M |
| Cost & Expenses | $719M |
| OPERATING INCOME | $23M |
| Interest Income | $28M |
| Interest Expense | $1M |
| Other Income/Expenses | $27M |
| INCOME BEFORE TAX | $50M |
| Income Tax Expense | $7M |
| Net Income from Continuing Ops | $43M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $43M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $43M |
| D&A | $24M |
| EBIT | $51M |
| EBITDA | $75M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $43M |
| Depreciation & Amortization | $24M |
| Stock-Based Compensation | $138M |
| Deferred Income Tax | $4M |
| Other Non-Cash Items | $40M |
| Change in Working Capital | -$31M |
| OPERATING CASH FLOW | $218M |
| Capital Expenditure | -$4M |
| Acquisitions (Net) | -$53M |
| Purchases of Investments | -$336M |
| Sales/Maturities of Investments | $501M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | $105M |
| Net Debt Issuance | -$508M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$46M |
| NET CASH FROM FINANCING | -$555M |
| FREE CASH FLOW | $214M |
| Net Change in Cash | -$233M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $645M |
| Short-Term Investments | $1.8B |
| Net Receivables | $463M |
| Inventory | $0 |
| Other Current Assets | $120M |
| TOTAL CURRENT ASSETS | $3.0B |
| PP&E (Net) | $104M |
| Goodwill | $5.5B |
| Intangible Assets | $106M |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $486M |
| TOTAL NON-CURRENT ASSETS | $6.2B |
| TOTAL ASSETS | $9.2B |
| Account Payables | $13M |
| Short-Term Debt | $350M |
| Deferred Revenue | $1.6B |
| Other Current Liabilities | $91M |
| TOTAL CURRENT LIABILITIES | $2.2B |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $29M |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $50M |
| TOTAL NON-CURRENT LIABILITIES | $152M |
| TOTAL LIABILITIES | $2.3B |
| Common Stock | $0 |
| Additional Paid-In Capital | $9.5B |
| Retained Earnings | -$2.6B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $4M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $6.9B |
| Minority Interest | $0 |
| TOTAL EQUITY | $6.9B |
| TOTAL LIABILITIES & EQUITY | $9.2B |
| Total Debt | $423M |
| Net Debt | -$222M |
